In silico Study of Pharmacological Treatments against SARS-CoV2 Main Protease

In silico Study of Pharmacological Treatments against SARS-CoV2 Main Protease

The COVID-19 caused by a new type of coronavirus has emerged from China and led to thousands of death globally. Despite the efforts engaged in studying this newly emerged virus and searching for its treatment, the understanding of the COVID-19 drug and target protein interactions still represent a...

Full description

Bibliographic Details
Main Authors: Youness Kadil, Mohamed Mouhcine, Houda Filali
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2020-05-01
Series:Journal of Pure and Applied Microbiology
Subjects:
covid-19
pharmacological treatment
protease
docking
sars-cov2
Online Access:https://microbiologyjournal.org/in-silico-study-of-pharmacological-treatments-against-sars-cov2-main-protease/

Internet

https://microbiologyjournal.org/in-silico-study-of-pharmacological-treatments-against-sars-cov2-main-protease/

Similar Items